TipRanks
HeraMED Ltd. (DE:1I4)
FRANKFURT:1I4
Germany Market
1I4
HeraMED Ltd.
RESEARCH TOOLSreports

HeraMED Ltd. (1I4) Ratios

0 Followers

HeraMED Ltd. Ratios

DE:1I4's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, DE:1I4's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 9.09 3.00 3.52 1.28 3.85
Quick Ratio
 9.09 3.00 2.95 1.04 3.64
Cash Ratio
 8.66 2.84 4.80 0.70 3.31
Solvency Ratio
 -5.82 -4.75 -3.18 -2.62 -3.76
Operating Cash Flow Ratio
 -9.31 -7.57 -4.57 -5.42 -3.17
Short-Term Operating Cash Flow Coverage
 0.00 -54.32 -18.98 -31.33 -14.06
Net Current Asset Value
$ 1.72M$ 406.80K$ 1.24M$ -233.86K$ 1.77M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.28 0.29 0.10 0.04
Debt-to-Equity Ratio
 0.00 0.45 0.48 0.45 0.06
Debt-to-Capital Ratio
 0.00 0.31 0.32 0.31 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.28 0.00 0.00 0.00
Financial Leverage Ratio
 1.23 1.60 1.62 4.32 1.45
Debt Service Coverage Ratio
 -6.15K -53.69 -16.31 -14.85 -1.16
Interest Coverage Ratio
 -6.17K -946.83 -115.30 -50.71 -1.24
Debt to Market Cap
 0.00 0.01 0.02 0.04 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Net Debt to EBITDA
 0.92 0.25 0.69 0.13 0.78
Profitability Margins
Gross Profit Margin
92.92%50.97%60.00%60.05%-99.48%
EBIT Margin
-2162.24%-1358.06%-1496.29%-1068.08%-1473.94%
EBITDA Margin
-2155.16%-1309.03%-1485.28%-961.33%-1466.70%
Operating Profit Margin
-2162.24%-1358.06%-2469.41%-1100.13%-1466.70%
Pretax Profit Margin
-2295.93%-1408.29%-1507.04%-1117.60%-2261.58%
Net Profit Margin
-2295.93%-1408.29%-1507.04%-1089.77%-2261.58%
Continuous Operations Profit Margin
-2295.93%-1408.29%-1507.04%-1117.60%-2261.58%
Net Income Per EBT
100.00%100.00%100.00%97.51%100.00%
EBT Per EBIT
106.18%103.70%61.03%101.59%154.20%
Return on Assets (ROA)
-109.42%-277.11%-122.44%-223.53%-116.52%
Return on Equity (ROE)
-198.77%-443.77%-198.14%-964.81%-169.25%
Return on Capital Employed (ROCE)
-115.61%-395.39%-262.29%-460.65%-93.30%
Return on Invested Capital (ROIC)
-115.61%-370.62%-216.36%-380.02%-88.61%
Return on Tangible Assets
-109.42%-277.11%-166.38%-286.27%-155.31%
Earnings Yield
-6.03%-10.72%-51.63%-107.95%-26.76%
Efficiency Ratios
Receivables Turnover
 1.68 7.16 1.39 1.20 1.24
Payables Turnover
 0.09 1.28 0.48 0.67 2.82
Inventory Turnover
 0.00 0.00 0.24 0.67 2.51
Fixed Asset Turnover
 1.88K 101.31 5.98 11.64 2.84
Asset Turnover
 0.05 0.20 0.08 0.21 0.05
Working Capital Turnover Ratio
 0.08 0.17 0.23 0.32 0.21
Cash Conversion Cycle
 -4.06K -233.62 1.02K 300.73 310.57
Days of Sales Outstanding
 216.94 51.00 262.52 303.67 294.68
Days of Inventory Outstanding
 0.00 0.00 1.52K 545.60 145.32
Days of Payables Outstanding
 4.28K 284.62 761.09 548.54 129.42
Operating Cycle
 216.94 51.00 1.78K 849.27 440.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.02 -0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.02 -0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.27
Dividend Paid and CapEx Coverage Ratio
 -726.79K -730.74K -1.49M -2.72K -3.71
Capital Expenditure Coverage Ratio
 -726.79K -730.74K -1.49M -2.72K -3.71
Operating Cash Flow Coverage Ratio
 0.00 -8.64 -3.65 -26.61 -14.06
Operating Cash Flow to Sales Ratio
 -21.23 -12.47 -13.21 -13.49 -11.70
Free Cash Flow Yield
-5.57%-9.49%-45.27%-133.65%-17.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -15.35 -9.24 -1.93 -0.93 -3.74
Price-to-Sales (P/S) Ratio
 380.93 131.32 29.19 10.09 84.51
Price-to-Book (P/B) Ratio
 22.34 41.38 3.84 8.94 6.32
Price-to-Free Cash Flow (P/FCF) Ratio
 -17.94 -10.53 -2.21 -0.75 -5.69
Price-to-Operating Cash Flow Ratio
 -17.94 -10.53 -2.21 -0.75 -7.23
Price-to-Earnings Growth (PEG) Ratio
 -0.30 0.16 0.03 0.05 0.07
Price-to-Fair Value
 22.34 41.38 3.84 8.94 6.32
Enterprise Value Multiple
 -16.76 -9.79 -1.27 -0.92 -4.99
Enterprise Value
 37.08M 25.08M 4.27M 3.66M 15.78M
EV to EBITDA
 -16.76 -9.79 -1.27 -0.92 -4.99
EV to Sales
 361.12 128.09 18.93 8.85 73.12
EV to Free Cash Flow
 -17.01 -10.27 -1.43 -0.66 -4.92
EV to Operating Cash Flow
 -17.01 -10.27 -1.43 -0.66 -6.25
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 >-0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 -0.02 -0.02
Tax Burden
 1.00 1.00 1.00 0.98 1.00
Interest Burden
 1.06 1.04 1.01 1.05 1.53
Research & Development to Revenue
 4.94 3.50 4.45 3.40 3.46
SG&A to Revenue
 12.73 6.09 12.66 4.12 11.63
Stock-Based Compensation to Revenue
 0.00 0.00 0.98 0.06 2.15
Income Quality
 0.92 0.89 0.88 1.24 0.52
Currency in USD